TOPIC TAGS for this article:
Pharma + Biotech, Litigation
U.S. District Court, District of New Jersey
Click on a topic to display all headlines on that subject
SSJR Successfully Defends its Client Sandoz Against Motion to Amend ANDA Complaint
9 December 2008
SSJR is pleased to report it has successfully defended its client Sandoz against a motion by Otsuka Pharmaceutical to amend an ANDA Complaint to add new claims for commercial and willful infringement.